Canary Speech

About:

Canary Speech is a technology company that uses AI-driven vocal digital biomarkers for conversational speech virtual health monitoring.

Website: http://www.canaryspeech.com

Twitter/X: canaryspeech

Top Investors: Sorenson Communications, Hackensack Meridian Health, Cortes capital, SMK Corporation

Description:

Canary Speech is a technology company that uses AI-driven vocal digital biomarkers for conversational speech virtual health monitoring. The company's vocal biomarker technology enables voice to be used as a vital sign, ushering in a new era of machine learning in healthcare. Using only 20 seconds of conversational speech, its patented vocal biomarker technology models acoustic and linguistic features and returns analysis. Canary detects stress, mood, and energy levels before traditional clinical screening and visible symptoms, allowing clinicians, payers, and patients to address conditions more proactively. Canary's technology reduces readmissions, prevents hospitalizations, and provides a head start on wellness for patients and providers. Its current research simulates respiratory conditions, dementia and Alzheimer's disease, and clinical deterioration, with broad practical implications for simulating other disease states.

Total Funding Amount:

$18.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Provo, Utah, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)canaryspeech.com

Founders:

Henry O'Connell

Number of Employees:

11-50

Last Funding Date:

2024-06-12

IPO Status:

Private

© 2024 MyAiNote.com